Leading Litigator Barbara Hart Joins Grant & Eisenhofer as Director and Member of Executive Committee
NEW YORK--(BUSINESS WIRE)--Jan 6, 2021--
Leading plaintiffs’ law firm Grant & Eisenhofer announced the arrival of Barbara Hart, a nationally recognized litigator with a distinguished track record of recoveries for investors in securities class actions as well as antitrust and whistleblower cases.
Ms. Hart joins G&E as a director and will serve as a member of the executive committee. She was previously president and CEO of national trial firm Lowey Dannenberg, where she long led the securities litigation practice and garnered some of the firm’s biggest settlements during her tenure.
She is the second major addition to G&E in recent months, following the arrival late last fall of noted mass tort litigator Sindhu Daniel to the firm’s Wilmington, Del., office. Ms. Daniel has helped structure multidistrict pharma and medical device settlements resulting in billions of dollars in recoveries to plaintiffs.
Both Ms. Hart and Ms. Daniel add to G&E’s growing list of women practice leaders including the Mass Tort Litigation group led by Elizabeth Graham; the Birth Injury Litigation group headed by Lisa Weinstein; the Delaware Corporate Governance Litigation group co-headed by Christine Mackintosh; and the Civil Rights/Gender-Based Torts Litigation group led by Kimberly Evans and Diandra Debrosse. G&E also boasts a female chief operating officer in Elise Martin.
Over a more than three-decade career, Ms. Hart has earned a spot among the nation’s most renowned advocates for public pension funds and institutional investors pursuing complex class action claims against major corporations. Her cases have often resulted in nine-figure recoveries for her clients. She has served as lead or co-lead counsel to plaintiffs in some of the largest securities class action settlements on record, as well as in significant price-fixing and collusion cases against global airlines, major food producers and healthcare providers.
Ms. Hart’s major cases include a $169 million settlement with Juniper Networks, the third-largest options backdating recovery ever; a $457 million securities recovery obtained for the State of Connecticut; a $285 million settlement for investors in securities sold by the El Paso Corp.; a $219 million recovery on behalf of Madoff investors; and the largest single New York Medicaid fraud recovery to date; among many others, including hundreds of millions of dollars in antitrust litigation settlements.
Following passage in 2019 of New York’s Child Victim Act, Ms. Hart has also taken on representation of some 45 adult survivors of sexual abuse bringing claims against the Roman Catholic Archdiocese of New York, Rockefeller University and the Boy Scouts of America.
“It’s an honor to welcome Barbara Hart to G&E,” said managing director Jay Eisenhofer. “She brings tremendous understanding of our historic representation of institutional investors as lead plaintiffs in large securities class actions, and her success in some of the biggest investor recoveries on record makes her a powerful addition to our team. Barbara also has an accomplished track record in antitrust, whistleblower and other areas of litigation where we practice, including her important work on behalf of victims of sexual abuse. Her leadership skills and vision will contribute immensely to the firm’s continued success.”
A respected speaker and writer on securities and antitrust matters, Ms. Hart was also instrumental in proposing changes to New York State’s stringent fraud and antitrust statutes, including granting consumers and other indirect purchasers standing to sue for damages under federal antitrust laws. She is a member of the Thirty Percent Coalition, an organization comprised of institutional investors, corporate partners, state treasurers and other entities – with a combined $7 trillion in assets under stewardship - whose mission is to increase diversity in corporate boardrooms.
Ms. Hart commented, “As a litigator, I’ve long admired Grant & Eisenhofer as one of the most preeminent law firms fighting for public pension funds and other plaintiffs in large scale, complex litigation matters. G&E is the perfect destination for me at this stage in my career. I’m excited to join an outstanding team of litigators, including a growing bench of women who have taken leadership roles in numerous disciplines at the firm such as medical device and pharmaceutical liability, mass torts and civil rights.”
Sindhu Daniel Background
Ms. Daniel arrives with an impressive portfolio of mass tort cases. She presently serves on a number of plaintiffs’ steering committees, such as the 3M Combat Arms Earplug Products Liability Litigation, the Talc and Proton Pump Inhibitor MDLs, as well as the Essure product liability lawsuits, in which Ms. Daniel represented plaintiffs alongside G&E. That litigation resulted in a $1.6 billion settlement for women who alleged that they sustained injuries from Bayer’s permanent birth control device Essure. In addition, she has played key leadership roles in major multidistrict litigation settlements involving Inferior Vena Cava Filters, Vioxx, Xarelto, DePuy Orthopaedics and other healthcare products. The cases she has handled have resulted in billions of dollars in settlement recoveries.
Commenting on Ms. Daniel’s recent arrival, Mr. Eisenhofer said, “Sindhu is one of the country’s premier mass torts practitioners, and we’re thrilled she’s joined to help expand our work in pharmaceutical, medical device and other products liability litigation. Our practice platform has grown significantly in the past several years beyond investor actions and Sindhu joins a dynamic group of women directors leading us into the future of plaintiffs’ advocacy.”
Ms. Daniel added, “I knew joining Grant & Eisenhofer would be an easy fit for me, and that I could make an impact growing the firm’s capacity in taking on major complex pharmaceutical and medical device cases, an area of litigation that continues to evolve. I was also impressed by G&E’s roster of women in leadership roles and helping build the firm’s brand.”
About Grant & Eisenhofer P.A.
Grant & Eisenhofer is one of the U.S.‘s leading litigation firms, with a highly successful track record representing plaintiffs in complex litigation and arbitration matters. The firm has offices in Wilmington (Delaware), New York, Chicago, Birmingham, and San Francisco, and an international docket of high-profile cases. G&E’s clients include institutional investors and other plaintiffs in U.S. and international securities matters, derivative and corporate governance lawsuits, shareholder activism matters, bankruptcy litigation, antitrust actions, consumer class actions, whistleblower cases involving the False Claims Act, mass tort and environmental suits, birth injury litigation, intellectual property disputes, and civil rights suits. The firm has recovered billions for clients in just the last few years, and has twice been cited by RiskMetrics for securing the highest average investor recovery in securities class actions. G&E has been named one of the country’s top plaintiffs’ law firms by The National Law Journal for more than a decade, and was named one of the U.S.’s “Most Feared Plaintiffs Firms” as well as one of Delaware’s “Regional Powerhouses for 2018″ by Law360. For more information, visit www.gelaw.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210106005741/en/
CONTACT: Allan Ripp firstname.lastname@example.org
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES MEDICAL DEVICES HEALTH LEGAL FINANCE BANKING
SOURCE: Grant & Eisenhofer P.A.
Copyright Business Wire 2021.
PUB: 01/06/2021 12:59 PM/DISC: 01/06/2021 12:59 PM